
India needs to focus on reducing dependency on single sources by qualifying other geographies
There are several challenges in the traceability of the pharma supply chain. They mainly consist of controllable factors such as managing shipment time, lead time, temperature excursions, and maintaining quality checks, and uncontrollable factors such as the Red Sea Crisis increased lead time and planning.
Companies and the industry need to work towards enhancing end-to-end traceability by improving forecast accuracy and ensuring adherence to compliance. Efforts must be taken to reduce lag/lead time, avoid temperature excursion, and ensure that all related documentation is completed and filled correctly. India pharma Inc. needs to focus on reducing dependency on imports and dependency on single sources by qualifying other geographies. In order to ensure quality control, supplier qualifications must include quality testing (Nitrosamine + other tests from national/government labs of the country).
Available solutions
◆ Track and trace mechanisms to be installed and monitored with validation in place
◆ Datalogger real-time online tracking/monitoring
◆ Temperature challenge: Pharma companies focus mainly on cold chain and ensure that the products are transported across the length and breadth of the country using cold chain transportation. In India, we are seeing a boom of reefer vehicles which are being used across industries.
◆ Depute 'speciality couriers' rather than the regular freight forwarders. Speciality couriers have a very tight TAT and monitoring mechanism from end to end. A few companies to name, PDP, Ontime Globe, Alisped etc
◆ Companies have moved from traditional USB data loggers to smart IOT-based loggers which give real-time monitoring of temperature during the transit of the products and storage in warehouses.
Diese Geschichte stammt aus der December 2024-Ausgabe von Express Pharma.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der December 2024-Ausgabe von Express Pharma.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden

THE LEADERSHIP PLAYBOOK: TECH, TALENT, TRANSFORMATION
Industry visionaries came together to shape the future of Indian pharma under the theme 'Leadership for the Next Leap' at Pharma Leadership and Innovation (PLI) Conclave 2025. The event explored strategies to drive innovation, sustainability and global leadership

COMPACTROL®: A new age diluent for pharma and nutra industries
COMPACTROL®, specially processed calcium sulfate dihydrate powder, is suitable as a filler in tablets manufactured by direct compression. It is also an effective diluent for two-piece hard capsule filling application

PUP SIT Assembly
Understanding the \"PUP SIT Assembly\" in the Single-Use Biopharmaceutical Industry
TRUTH interchangeable glass syringe
Top Syringe exports its products to over 40 countries worldwide and counting, keeping a single quality standard for local and export products

Highly flexible blister production at Remedica
The blister machines and cartoners at Remedica's manufacturing site in Limassol, Cyprus, are arranged in-line in a so-called Z-layout. Romaco tailored the configuration to meet Remedica's needs exactly

Ensuring clean room integrity with Prime Clean Reset high-speed doors
These high-speed doors are meticulously engineered to minimise air leakage and maintain strict environmental control, making them indispensable for clean room operations

Being complacent in pharma quality: Five minutes to midnight
Dr Sumedha Nadkar, Pharma Consultant and Visiting Faculty, shares a hard hitting article which highlights that complacency in pharma quality can have devastating consequences, eroding hard- earned trust and endangering lives. She urges that urgent action is needed to safeguard its reputation and reinforce ethical responsibility

India's CRDMO sector growth potential at $22 - $25 bn by 2035: BCG-IPSO Report
Report states that India's CRDMO sector is poised for rapid growth with strong fundamentals and global realignments, focusing on leading-edge science and technology, Excerpts from the report

Leadership evolution in India's pharma sector in 2025
As the sector adapts to technological advancements, regulatory requirements, and increasing competition, several leadership role trends are emerging to drive global growth and innovation, highlights Tarunesh Madan, Co-Managing Partner, Amrop India

Flexotherm Heating Tapes & Cords
lexotherm Heating Tape ensures uniform heating in incubators, laboratory reactors, and diagnostic equipment